ID: ALA3087799

Max Phase: Preclinical

Molecular Formula: C12H18ClFN2O2S

Molecular Weight: 308.81

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCN(CC)CCNS(=O)(=O)c1ccc(Cl)cc1F

Standard InChI:  InChI=1S/C12H18ClFN2O2S/c1-3-16(4-2)8-7-15-19(17,18)12-6-5-10(13)9-11(12)14/h5-6,9,15H,3-4,7-8H2,1-2H3

Standard InChI Key:  VLPBXPNLXYJRHU-UHFFFAOYSA-N

Associated Targets(non-human)

Acetylcholinesterase 1323 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 308.81Molecular Weight (Monoisotopic): 308.0762AlogP: 2.10#Rotatable Bonds: 7
Polar Surface Area: 49.41Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.42CX Basic pKa: 7.80CX LogP: 1.77CX LogD: 1.49
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.84Np Likeness Score: -2.46

References

1. Andersson CD, Forsgren N, Akfur C, Allgardsson A, Berg L, Engdahl C, Qian W, Ekström F, Linusson A..  (2013)  Divergent structure-activity relationships of structurally similar acetylcholinesterase inhibitors.,  56  (19): [PMID:23984975] [10.1021/jm400990p]

Source